Itamar Medical Sees Growth in Sleep Disorder, Heart Markets
Third quarter results to reflect three new sales deals, and the company raised $16.3 million to boost R&D and commercialization, Reuters reports. Israel’s Itamar Medical expects to end three years of sluggish growth...
Read More